Consensus statement on the use of Xelma in diabetic foot ulcers

MCINNES, ALISTAIR (2010) Consensus statement on the use of Xelma in diabetic foot ulcers Diabetic Foot, 13 (3). pp. 148-151. ISSN 1462-2041

Full text not available from this repository.

Abstract

Diabetic foot ulcers are a common and costly complication of diabetes, often presenting in a chronic wound state. Adjuvant therapies may be used to kick-start the healing process in hard-to-heal and chronic wounds, but specific placement of these therapies in the care pathway is not always clear. A group of experienced clinicians developed the following consensus statement and treatment algorithm on the use of the extracellular matrix protein therapy Xelma (Mölnlycke Health Care, Dunstable) specifically in diabetic foot ulcers.

Item Type: Journal article
Subjects: B000 Health Professions > B600 Health Research
Faculties: Faculty of Health and Social Sciences > School of Health Professions
Depositing User: Converis
Date Deposited: 24 May 2012 13:58
Last Modified: 09 Jan 2013 08:12
URI: http://eprints.brighton.ac.uk/id/eprint/10564

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year